Takeda grants 43,886 ADS RSUs to OBU president
Bitetti Teresa Marie reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Bitetti Teresa Marie reported acquisition or exercise transactions in this Form 4 filing.
Takeda Pharmaceutical reported that Teresa Marie Bitetti, President of its Oncology Business Unit, received an equity award of 43,886 American Depositary Shares (ADSs) in the form of restricted stock units (RSUs). Each RSU represents the right to receive one ADS if vesting conditions are met.
The RSUs vest in three equal annual installments beginning on July 1, 2027, which means the award is tied to continued service over several years. After this grant, Bitetti directly holds 302,022 ADSs, reflecting her ongoing long-term ownership stake aligned with shareholders.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | American Depositary Shares | 43,886 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest in three equal annual installments beginning on July 1, 2027.
Key Figures
Key Terms
restricted stock units (RSUs) financial
vest in three equal annual installments financial
grant, award, or other acquisition financial
FAQ
What insider transaction did Takeda (TAK) report for Teresa Marie Bitetti?
How do the new RSUs granted to Takeda (TAK) executive Teresa Bitetti vest?
Was Teresa Marie Bitetti’s Takeda (TAK) RSU grant an open-market stock purchase?
What does each RSU represent in Teresa Bitetti’s Takeda (TAK) award?
AI-generated analysis. How Rhea-AI works. Not financial advice.